Neurology

A new treatment for MS was found effective in animal models.

Specially synthesized plant peptide cyclotide found to suppress onset of multiple sclerosis.

Top news of the day from across the health care landscape.

A large proportion of patients with multiple sclerosis experience taste deficits.

Have you ever considered pursuing a post-graduate year 2 pharmacy residency in neurology?

Signs of multiple sclerosis may be found via magnetic resonance imaging scanners in the near future.

Individual genetic backdrop may be less important than previously thought in the development of multiple sclerosis.

Significant differences found in the occurrence and type of comorbidity in male and female patients with MS.

Most of MS medications require regular blood tests to track how the drug is affecting the body.

Possible side effects for multiple sclerosis medications can range from mild to life-threatening.

Six or more cups of coffee per day associated with a reduced risk in the onset of multiple sclerosis symptoms.

Patients with MS also have higher rates for conditions such as high blood pressure, diabetes, heart disease, chronic lung disease, epilepsy, and inflammatory bowel disease.

Researchers evaluate fingolimod (Gilenya) in patients with highly active relapsing remitting multiple sclerosis.

Combination of metformin and pioglitazone shows a significant decrease in the number of new or enlarging brain lesions in MS patients.

Researchers evaluate the link between vitamin D and multiple sclerosis development.

The day-to-day struggle of a mom dealing with the symptoms of multiple sclerosis.

Phenytoin may help reduce the symptoms of multiple sclerosis.

Ocrelizumab shows promise reducing symptoms of MS.

Ocrelizumab selectively targets CD20+B cells to reduce disease activity in patients with primary progressive multiple sclerosis.

Protein regulator may lead to new multiple sclerosis treatments.

High doses of biotin show promise in progressive multiple sclerosis.

Research seeks to determine the genetic and environmental risk factors that trigger MS.

Gut microbiota poses a curious question in MS development and research.

Researchers explore possible reasons why HIV-positive patients have a decreased risk of MS.

Most MS patients have not considered changing their diet as a therapeutic approach.